Sato, Akira <br/><br/>
Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3'-ethynylcytidine treatment of human cancer cells.  [electronic resource] 

 -  Anti-cancer drugs  08 2017 
 - 781-786 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cytidine--analogs & derivatives<br/>Fibrosarcoma--drug therapy<br/>Humans<br/>Neoplasms--drug therapy<br/>Point Mutation<br/>RNA Precursors--genetics<br/>RNA Splicing<br/>RNA, Messenger--biosynthesis<br/>Uridine Kinase--genetics